Belite Bio (BLTE) Accumulated Expenses (2021 - 2025)
Belite Bio (BLTE) posted quarterly Accumulated Expenses of $1.6 million for Q4 2025, up 129.02% year-over-year from $703000.0 in Q4 2024, and down 79.34% quarter-over-quarter from $7.8 million in Q3 2025.
Belite Bio (BLTE) Accumulated Expenses (2021 - 2025) Analysis & Trends
Belite Bio's Accumulated Expenses history runs 5 years deep, the most recent figure standing at $1.6 million for Q4 2025.
- In Q4 2025, Accumulated Expenses rose 129.02% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 129.02% YoY), while the FY2025 annual figure was $1.6 million, up 129.02% from the prior year.
- Accumulated Expenses for Q4 2025 stood at $1.6 million, down from $7.8 million in the prior quarter.
- The five-year high for Accumulated Expenses was $7.8 million in Q3 2025, with the low at $56000.0 in Q4 2021.
- The 5-year median for Accumulated Expenses is $1.8 million (2022), against an average of $2.6 million.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses soared 3303.57% in 2022, then sank 78.86% in 2024.
- Belite Bio's Accumulated Expenses stood at $56000.0 in 2021, then jumped by 3303.57% to $1.9 million in 2022, then soared by 74.45% to $3.3 million in 2023, then tumbled by 78.86% to $703000.0 in 2024, then soared by 129.02% to $1.6 million in 2025.
- Business Quant data shows BLTE's Accumulated Expenses at $1.6 million in Q4 2025, $7.8 million in Q3 2025, and $703000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 7.79 Mn |
| Dec 31, 2024 | 703,000.00 |
| Dec 31, 2023 | 3.33 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 56,000.00 |